Explore evidence

The B.1.1.7 variant of SARS-CoV-2 was introduced to Gabon in December 2020.

GabonCOVID-19observed December 2020published 2021Journal of medical virologyeurope_pmcdocument of 2 observationsDOI 10.1002/jmv.27164

5.6 %At 33–38 weeks, 5.6% of fetuses had estimated fetal weight below the 10th percentile according to INTERGROWTH-21st standards.

Gabonfetal growth restrictionpublished 2022PloS oneeurope_pmcdocument of 5 observations

6.2 %Among 16 sequenced HIV-1 samples, subtype F2 accounted for 6.2% of strains.

Gabonsubtype F2 · VIH/sidaobserved 2020–2021published 2023BMC infectious diseasesPubMeddocument of 8 observations

3.51 %The IC50 values for Caucasian sera against PVL and α-hemolysin were 3.51% and 3.59%, respectively.

GabonPanton-Valentine leukocidin (PVL) positive S. aureuspublished 2022BMC microbiologyeurope_pmcdocument of 2 observations

22.3 %The overall sporozoite infection rate was 22.3%.

Gabonpaludismeobserved 2021published 2024Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/s12936-023-04823-9

6.8 %The prevalence of Plasmodium falciparum in interior forest was 6.8%.

Gabonpaludismepublished 2011Malaria JournalOpenAlexdocument of 10 observationsDOI 10.1186/1475-2875-10-33

9 %Urogenital schistosomiasis was diagnosed in 9% of 1115 pregnant women attending antenatal clinics in Fougamou and Lambaréné, Gabon.

Gabonschistosomiasepublished 2017International journal for parasitologyeurope_pmcdocument of 7 observations

94 %After the first dose of praziquantel, the egg reduction rate was 94% for heavy infections and 89% for light infections.

Gabonschistosomiasepublished 2019Parasites & vectorseurope_pmcdocument of 20 observations

3 log10_copies_per_mlMean HIV-1 viral load was Log 3.0 (± 1.6) copies/ml in HIV-1 mono-infected individuals.

GabonVIH/sidapublished 2022PloS onePubMeddocument of 12 observations

36.3 %Malaria was confirmed for 49 (36.3%) patients among 135 febrile patients screened in Gabon from October 2021 to December 2021.

Gabonpaludismeobserved October 2021 to December 2021published 2022Southern African journal of infectious diseaseseurope_pmcdocument of 4 observations

7.7 %Infections caused by high-risk human papillomavirus (HPV) are responsible for 7.7% of cancers in developing countries, mainly cervical cancer.

Gaboncancer du col de l'utérus · infection à HPVpublished 2017Expert review of anti-infective therapyPubMeddocument of 3 observations

79 %79% of samples from the low IPTp-SP coverage period had a submicroscopic infection in Gabon.

Gabonpaludismepublished 2014Malaria research and treatmenteurope_pmcdocument of 5 observations

Anti-H1N1 and anti-B antibody responses after influenza vaccination were weaker in rural schoolchildren than in semi-urban schoolchildren in Gabon.

Gabongrippepublished 2007The Journal of infectious diseaseseurope_pmcdocument of 3 observationsDOI 10.1086/522010

45 %The overall rectal colonization rate of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) among 200 hospitalized children in Gabon was 45%.

Gabonextended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E)published 2013The Journal of antimicrobial chemotherapyeurope_pmcdocument of 3 observationsDOI 10.1093/jac/dkt164

500 pg/mlIFN-γ levels were 500 ± 100.2 pg/ml in Gabonese children with severe Plasmodium falciparum malaria anemia.

Gabonsevere Plasmodium falciparum malaria anemiapublished 2017American journal of clinical and experimental immunologyeurope_pmcdocument of 9 observations

10.9 %Heterocellular and pancellular forms of hereditary persistence of foetal haemoglobin occurred at rates of 10.9% and 2.3%, respectively, among 787 subjects diagnosed in Franceville, Gabon.

Gabonhereditary persistence of foetal haemoglobinpublished 2017HematologyOpenAlexdocument of 4 observationsDOI 10.1080/10245332.2017.1292622

85.7 %Among clinical ESBL-PE isolates in Gabon, 85.7% harbored one to three β-lactamase-encoding genes (blaTEM-1, blaOXA-1, or blaSHV-1).

GabonExtended-spectrum beta-lactamase-producing Enterobacteriaceaepublished 2021Microbial drug resistance (Larchmont, N.Y.)europe_pmcdocument of 11 observations

3,206,000 US_dollar_per_yearThe annual monetary burden estimate for loiasis in the rural population of Gabon is US-$3,206,000 (95% CI: 1,150,000–5,577,000).

Gabonloasepublished 2024PLoS neglected tropical diseaseseurope_pmcdocument of 9 observationsDOI 10.1371/journal.pntd.0012389

40,000,000 inhabitantsAround 40 million people live in high or intermediate-risk areas for L. loa in West- and Central Africa.

GabonL. loapublished 2024PLoS neglected tropical diseaseseurope_pmcdocument of 7 observations

220 patientsDuring the study, 220 patients had severe malaria.

Gabonpaludismepublished 2023Malaria journaleurope_pmcdocument of 25 observationsDOI 10.1186/s12936-023-04512-7

44.57 %The Abbott RealTime High-Risk HPV test detected at least one HPV genotype in 44.57% of women regardless of the grade of cervical abnormalities.

Gaboninfection à HPVpublished 2017Virology journalPubMed

30.5 %Helminth infection was present in 77 out of 252 HIV-infected adults, corresponding to a prevalence of 30.5%.

Gabonhelminth infectionpublished 2015PLoS neglected tropical diseaseseurope_pmcdocument of 6 observations

36 %The most frequent haplotypes were those with a single mutation (N CNIAKA) in 36% of the Plasmodium falciparum isolates from HIV-infected adults in Gabon.

Gabonpaludismeobserved 2015–2016published 2019Malaria research and treatmenteurope_pmcdocument of 7 observationsDOI 10.1155/2019/9523259

54 casesTests were positive for at least one target organism in the test panel in 54 of 104 cases (52%).

Gabonsexually transmitted infectionsobserved March 2023-March 2024published 2025IJID regionsPubMeddocument of 7 observations

35.5 %Anemia was classified as mild in 35.5% of the 723 first-time blood donors from Lambaréné.

Gabonanémieobserved March 2018 to October 2019published 2024Balkan medical journaleurope_pmcdocument of 7 observations